David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon

Analyst Articles

Stocks seem to have stabilized as the trading week came to a close, but investors continue to wrestle with the market’s next move. Shares are noticeably cheaper than a few months ago, but the risks of an economic slowdown have increased. For those… Read More

In a bid to keep a lid on runaway prescription drug prices, many companies have turned to Pharmacy Benefit Managers (PBMs). These firms act as a middleman, handling all prescription-related paperwork and gently nudging consumers toward lower-priced generic drugs and an increased use of low-cost mail-order services. Over time, the… Read More

Warren Buffett seemed to take it on the chin last week. In fact, he’s been hammered for a couple of months now. First came the annual Berkshire Hathaway (NYSE: BRK-B) shareholders meeting, the annual Woodstock for Capitalists and Buffett love fest held each May,… Read More

Among the biggest winners in Friday’s early trading are Wendy’s/Arby’s (NYSE: WEN), IDT Corp. (NYSE: IDT) and ArcSight (Nasdaq: ARST). Top Percentage Gainers — Friday, June 11, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Gain 52-Week High 52-Week Low ArcSight (Nasdaq: ARST) $24.27 +22.5% $29.33 $14.23 IDT… Read More

My friend Chris was irate. “My broker just ripped me off!” he pouted. “Royal Dutch Shell (NYSE: RDS-A) said in a press release they would pay $0.84 a share, but instead my broker gave me $0.714 a share.” I tried to explain to Chris that it’s not… Read More

The past decade has been tough for stocks, with the bursting of the Internet and housing bubbles creating share price volatility too extreme for many investors. As for blue chip companies, sky-high valuations in 2000 have left little in terms of total stock returns, even though… Read More

Among the biggest losers in Thursday’s early trading are Walgreen (NYSE: WAG), Contango (AMEX: MCF) and School Specialty (Nasdaq: SCHS). Top Percentage Losers –Thursday, June 10, 2010 Company Name (Ticker) Intra-Day Price Intra-Day % Loss 52-Week High 52-Week Low School Specialty (Nasdaq: SCHS) $18.81 -6.6% $25.29… Read More

During my former days as a financial advisor, I’d occasionally get a call or email from someone in our “Alternative Investments” department trying to drum up business. Invariably, they wanted me to deposit my clients’ assets into a specialized hedge fund utilizing one esoteric strategy or another. Quite… Read More